Associate Professor Christina Reith
Colleges
Websites
-
Royal College of Physicians and Surgeons of Glasgow
Fellow
-
Faculty of Pharmaceutical Medicine
Fellow
-
Cholesterol Treatment Trialists' Collaboration
Secretariat member
-
CDISC
Board Member
-
Good Clinical Trials Collaborative
Working Group Member
-
Clinical Trials Transformation Initiative
Working Group Member
Christina Reith
BSc (Hons), MBChB (Hons), PhD, FRCP, FFPM
Associate Professor
- Honorary Consultant Physician, Pharmaceutical Medicine, Oxford University Hospitals NHS Foundation Trust
Christina is actively involved in supervision and training, teaching on two MSc courses, being a GMC-approved Educational Supervisor for Pharmaceutical Medicine specialty training, and acting as a College Adviser for students at Green Templeton College.
Christina is also a keen proponent of streamlined clinical trial methodology, and is a Board Member for the Clinical Data Interchange Standards Consortium (CDISC) which aims to develop and advance high quality data standards.
Since joining the Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU) in 2004, Christina has mainly worked on large-scale clinical trials. These include: the Study of Heart and Renal Protection [SHARP] in patients with moderate-to-severe chronic kidney disease, which recruited >9000 patients in nearly 400 hospitals in 18 countries); and, individual participant data meta-analyses in relation to cardiovascular disease, such as those conducted by the Cholesterol Treatment Trialists’ (CTT) Collaboration, and the Antithrombotic Trialists’ (ATT) Collaboration.
Christina completed her MRCP whilst working in the NHS, and subsequently completed speciality training in Pharmaceutical Medicine in 2011. She became a Fellow of The Royal College of Physicians and Surgeons of Glasgow in 2012, and a Fellow of the Faculty of Pharmaceutical Medicine in 2013.
Christina studied at The University of Glasgow, gaining a first class honours degree in medical biochemistry and subsequently her medical degree with honours.
She has a particular research interest in the reliable assessment of drug safety using large-scale randomised data.